Filtrer les publications
Epidemiology of travel-associated dengue from 2007 to 2022: A GeoSentinel analysis
18. Duvignaud A, Stoney RJ, Angelo KM, Chen LH, Cattaneo P, Motta L, Gobbi FG, Bottieau E, Bourque DL, Popescu CP, Glans H, Asgeirsson H, Oliveira-Souto I, Vaughan SD, Amatya B, Norman FF, Waggoner J, Díaz-Menéndez M, Beadsworth M, Odolini S, Camprubí-Ferrer D, Epelboin L, Connor BA, Eperon G, Schwartz E, Libman M, Malvy D, Hamer DH, Huits R, GeoSentinel Network
Journal: J Travel Med 31(7):taae089
Voir la publicationHIV-1 subtype-specific drug resistance on dolutegravir-based antiretroviral therapy: protocol for a multicentre longitudinal study (DTG RESIST)
19. Egger M, Sauermann M, Loosli T, Hossmann S, Riedo S, Beerenwinkel N, Jaquet A, Minga A, Ross JL, Giandhari J, Kouyos R, Lessells R
Journal: medRxiv :2024.05.23.24307850
Voir la publicationEfficacy and safety of three antiretroviral therapy regimens for treatment-naive African adults living with HIV-2 (FIT-2): a pilot, phase 2, non-comparative, open-label, randomised controlled trial
20. Eholie SP, Ekouevi DK, Chazallon C, Charpentier C, Messou E, Diallo Z, Zoungrana J, Minga A, Ngom Gueye NF, Hawerlander D, Dembele F, Colin G, Tchounga B, Karcher S, Le Carrou J, Tchabert-Guié A, Toni T, Ouédraogo A-S, Bado G, Toure Kane C, Seydi M, Poda A, Mensah E, Diallo I, Drabo YJ, Anglaret X, Brun-Vezinet F, FIT-2 study group
Journal: Lancet HIV 11(6):e380–e388
Voir la publicationPrevalence of pretreatment HIV resistance to integrase inhibitors in West African and Southeast Asian countries
1. Aghokeng AF, Ngo-Giang-Huong N, Huynh THK, Dagnra AY, D’Aquin Toni T, Maiga AI, Dramane K, Eymard-Duvernay S, Chaix M-L, Calvez V, Descamps D
